| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
uniQure N.V (NASDAQ: QURE)
QURE Technical Analysis
3
| As on 9th Jun 2023 QURE STOCK Price closed @ 19.61 and we RECOMMEND Buy for LONG-TERM with Stoploss of 18.59 & Buy for SHORT-TERM with Stoploss of 18.49 we also expect STOCK to react on Following IMPORTANT LEVELS. |
QURESTOCK Price
| Open | 20.82 | Change | Price | % |
| High | 20.82 | 1 Day | -1.18 | -5.68 |
| Low | 19.29 | 1 Week | 0.16 | 0.82 |
| Close | 19.61 | 1 Month | 0.13 | 0.67 |
| Volume | 430487 | 1 Year | -1.62 | -7.63 |
| 52 Week High 27.32 | 52 Week Low 13.15 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| QURE Daily Charts |
QURE Intraday Charts |
Whats New @ Bazaartrend |
QURE Free Analysis |
|
|
QURE Important Levels Intraday
| RESISTANCE | 22.56 |
| RESISTANCE | 21.61 |
| RESISTANCE | 21.03 |
| RESISTANCE | 20.44 |
| SUPPORT | 18.78 |
| SUPPORT | 18.19 |
| SUPPORT | 17.61 |
| SUPPORT | 16.66 |
QURE Forecast May 2024
| 4th UP Forecast | 29.44 |
| 3rd UP Forecast | 26.29 |
| 2nd UP Forecast | 24.34 |
| 1st UP Forecast | 22.39 |
| 1st DOWN Forecast | 16.83 |
| 2nd DOWN Forecast | 14.88 |
| 3rd DOWN Forecast | 12.93 |
| 4th DOWN Forecast | 9.78 |
QURE Weekly Forecast
| 4th UP Forecast | 23.87 |
| 3rd UP Forecast | 22.50 |
| 2nd UP Forecast | 21.66 |
| 1st UP Forecast | 20.81 |
| 1st DOWN Forecast | 18.41 |
| 2nd DOWN Forecast | 17.56 |
| 3rd DOWN Forecast | 16.72 |
| 4th DOWN Forecast | 15.35 |
QURE Forecast2024
| 4th UP Forecast | 49.92 |
| 3rd UP Forecast | 40.2 |
| 2nd UP Forecast | 34.19 |
| 1st UP Forecast | 28.18 |
| 1st DOWN Forecast | 11.04 |
| 2nd DOWN Forecast | 5.03 |
| 3rd DOWN Forecast | -0.98 |
| 4th DOWN Forecast | -10.7 |
uniQure N.V ( NASDAQ USA Symbol : QURE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
QURE Business Profile
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-180 for the treatment of hemophilia A; AMT-190, an IV-administered adeno-associated virus (AAV) 5-based gene therapy for the treatment of Fabry disease; and AMT-150, a one-time, intrathecally-administered, AAV gene therapy for treating spinocerebellar ataxia type 3. The company has collaboration and license agreements with Bristol Myers-Squibb Company; Gen-X; and Synpromics Limited. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Address: Paasheuvelweg 25a, Amsterdam, Netherlands, 1105 BP
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service